Novo Nordisk stock traded higher in the U.S. after the U.K.’s healthcare regulator approved a higher dose of Novo’s ...

Weight-loss giant Novo Nordisk's shares rose over 5% on Friday ​to a high last touched in October, ‌driven by "encouraging" ...

The early data is a boost to the Danish drugmaker's hopes of winning back more market share from Eli Lilly this year in the ...

Britain's health regulator approved a maximum weekly dose of up to 7.2 milligrams of Novo Nordisk's blockbuster weight-loss ...

Does the new Wegovy pill work as well as Wegovy injections for weight loss? How else does it compare? Learn what the experts ...

Shares in Denmark's global healthcare company, Novo Nordisk jumped sharply on Friday after the U.K.'s regulator signed off on ...

Novo Nordisk stock rose 4% after the U.K. approved a higher 7.2mg Wegovy dose and early prescription data showed strong ...

Investing.com -- The Medicines and Healthcare products Regulatory Agency approved a maximum dose of up to 7.2 milligrams per week of Novo Nordisk’s (CSE:NOVOb) weight-loss drug Wegovy for patients ...

Health-care companies rose after a strong launch for one potential blockbuster. The pill formulation of Danish drug maker Novo Nordisk's Wegovy weight-control medication garnered almost as many ...

Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments ...

COPENHAGEN, Jan 5 () - Denmark's Novo Nordisk will offer its 1.5 ​and 4 milligram Wegovy weightloss pills ‌at $149 per month ...

Novo Nordisk executive Dave Moore touted high interest in Wegovy's oral version of its injectable GLP-1 weight-loss ...